Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

NNVC

NanoViricides (NNVC)

NanoViricides Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:NNVC
DateTimeSourceHeadlineSymbolCompany
09/22/20216:45AMPR Newswire (US)Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral DrugAMEX:NNVCNanoViricides Inc
09/21/202111:25AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:NNVCNanoViricides Inc
09/14/20217:02AMInvestorsHub NewsWireNanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug DevelopmentAMEX:NNVCNanoViricides Inc
09/14/20216:53AMPR Newswire (US)NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug DevelopmentAMEX:NNVCNanoViricides Inc
03/09/20219:30AMInvestorsHub NewsWireNanoViricides, Inc. Pan-coronavirus COVID-19 Drug Candidates Are Highly Effective in Pre-clinical Animal Studies in ....ContAMEX:NNVCNanoViricides Inc
03/02/20217:00AMInvestorsHub NewsWireNanoViricides, Inc. Pan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinicalAMEX:NNVCNanoViricides Inc
02/17/20217:00AMInvestorsHub NewsWireNanoViricides Has Filed Quarterly Report for Period Ending December 31, 2020 - Has Sufficient Cash, Coronavirus Drug ....contAMEX:NNVCNanoViricides Inc
02/16/20214:40PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:NNVCNanoViricides Inc
02/16/20219:48AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:NNVCNanoViricides Inc
02/08/20216:36AMInvestorsHub NewsWireNanoViricides's Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP..C...AMEX:NNVCNanoViricides Inc
01/27/20217:00AMInvestorsHub NewsWireBroad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus VariantsAMEX:NNVCNanoViricides Inc
01/26/202111:05AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:NNVCNanoViricides Inc
01/04/202111:45AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:NNVCNanoViricides Inc
12/10/20204:31PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:NNVCNanoViricides Inc
12/03/20204:31PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:NNVCNanoViricides Inc
11/19/20204:53PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:NNVCNanoViricides Inc
11/19/20206:47AMInvestorsHub NewsWireNanoViricides Strengthens its Board of Directors with Addition of Industry Veteran Brian Zucker, CPAAMEX:NNVCNanoViricides Inc
11/16/20204:33PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:NNVCNanoViricides Inc
11/11/20207:14AMInvestorsHub NewsWireNanoViricides Has Engaged Calvert Labs for Safety Pharmacology Studies of Its Drug for the Treatment of COVID-19AMEX:NNVCNanoViricides Inc
10/26/20204:25PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:NNVCNanoViricides Inc
10/13/20205:23PMEdgar (US Regulatory)Annual Report (10-k)AMEX:NNVCNanoViricides Inc
09/16/20207:17AMInvestorsHub NewsWireNanoViricides Nominates a Novel Candidate for Advancing Into Clinical Trials for Treatment of COVID-19AMEX:NNVCNanoViricides Inc
08/03/20205:20PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:NNVCNanoViricides Inc
07/31/20205:30PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:NNVCNanoViricides Inc
07/21/20209:42AMInvestorsHub NewsWireNanoViricides to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit Today, July 21, 2020AMEX:NNVCNanoViricides Inc
07/20/20203:29PMEdgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:NNVCNanoViricides Inc
07/13/20204:53PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:NNVCNanoViricides Inc
07/08/20208:00AMInvestorsHub NewsWireSafety and Tolerability of Anti-Coronavirus Drug Candidates Observed in an Animal Model Further Advances NanoViricides' SARS-...AMEX:NNVCNanoViricides Inc
06/04/20204:50PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:NNVCNanoViricides Inc
05/29/202010:43AMEdgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:NNVCNanoViricides Inc
 Showing the most relevant articles for your search:AMEX:NNVC

Your Recent History

Delayed Upgrade Clock